Whoever thought they would see anything below a $1 will be...

Whoever thought they would see anything below a $1 will be disappointed

Great timing.....better top up....should be chasing after Mesoblast now........$1.30

Wooooosh!!!

What a great shareholder update

Since receiving the FDA’s request for confirmatory clinical data, Starpharma has undertaken a comprehensive program with a view to expediting approval, which has included extensive regulatory advice from FDA experts and specialist US legal counsel. The information submitted for the meeting, which includes additional statistical analyses of existing data, was prepared in consultation with, and following input from Starpharma’s team of expert FDA consultants, including former senior FDA personnel, KOLs and statisticians. These analyses provide further support for the approval of VivaGel® BV.